D. Ennist

发表

Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL

K. Burroughs, D. Kayda, K. Sakhuja, 2004, Cancer Gene Therapy.

D. Ennist, 1999, Trends in pharmacological sciences.

Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosis

Albert A. Taylor, Samad Jahandideh, D. Ennist, 2018, Amyotrophic lateral sclerosis & frontotemporal degeneration.

CG0070, a Conditionally Replicating Granulocyte Macrophage Colony-Stimulating Factor–Armed Oncolytic Adenovirus for the Treatment of Bladder Cancer

D. Ennist, Y. Ge, S. Ganesh, 2006, Clinical Cancer Research.

Rapid method for identification of macrophages in suspension by acid alpha-naphthyl acetate esterase activity.

D. Ennist, K. H. Jones, K. Jones, 1983, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Requirement for BSF-1 in the induction of antigen-specific B cell proliferation by a thymus-dependent antigen and carrier-reactive T cell line.

T. Mosmann, D. Ennist, M. Howard, 1987, Journal of immunology.

In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF.

J. Bristol, D. Ennist, Lori Clarke, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

In vivo delivery of interleukin-4 by a recombinant vaccinia virus prevents tumor development in mice.

D. Ennist, K. Elkins, J. Weir, 1994, Human gene therapy.

Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS

S. Paganoni, V. Drory, J. Shefner, 2022, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Human B-lymphocyte colony responses: suboptimal colony responsiveness in aged humans associated with defective function of B cells and monocytes.

D. Ennist, L. Lachman, R. Whisler, 1985, Cellular immunology.

An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes.

E. Appella, K. Ozato, M. Marks, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Negative Transcription Factor That Binds to the Upstream Conserved Region of Moloney Murine Leukemia Virus

K. Becker, E. Appella, K. Ozato, 2003 .

Thymidine kinase (TK) gene-transduced human lymphocytes can be highly purified, remain fully functional, and are killed efficiently with ganciclovir.

B. Barlogie, N. Munshi, G. Tricot, 1997, Blood.

Canine T cells transduced with a herpes simplex virus thymidine kinase gene: a model to study effects on engraftment and control of graft-versus-host disease.

R. Storb, D. Ennist, P. Malik, 1998, Transplantation.

Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis tool

Albert A. Taylor, E. Pioro, D. Ennist, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Modulation of immune responses by surface polysaccharides of Candida albicans.

D. Ennist, P. Baker, K. Elkins, 1988, Reviews of infectious diseases.

DIFFERENTIAL EFFECTS OF TRYPTOPHAN PHOTOPRODUCTS AND H2O2 ON THE GROWTH OF MOUSE EMBRYONIC FIBROBLASTS *

D. Ennist, J. D. Hare, S. Zigman, 1978, Photochemistry and photobiology.

Nonspecific inflammation inhibits adenovirus-mediated pulmonary gene transfer and expression independent of specific acquired immune responses.

B. Trapnell, D. Ennist, K. Harrod, 1998, Human gene therapy.

Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide

Karen L. Elkins, Douglas E. Brenneman, David L. Ennist, 1988, Nature.

Biosafety monitoring of patients receiving intracerebral injections of murine retroviral vector producer cells.

P. Ryan, D. Ennist, G. Mcgarrity, 1998, Human gene therapy.

Activity of a partially purified human BCGF on murine assays for B-cell stimulatory factors. I. BCGF II-like activity of human BCGF.

R. Coffman, D. Ennist, M. Howard, 1987, Cellular immunology.

Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus

B Z Levi, K. Becker, E. Appella, 1992, Molecular and cellular biology.

The genomic structure of the murine ICSBP gene reveals the presence of the gamma interferon-responsive element, to which an ISGF3 alpha subunit (or similar) molecule binds

J. Darnell, C. Kozak, C. Schindler, 1993, Molecular and cellular biology.

Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein

D. Ennist, P. Baker, P. Stashak, 1987, Infection and immunity.

Activation of immunoglobulin control elements in trasgenic mice

K. Ozato, D. Ennist, H. Westphal, 2004, Immunogenetics.

Pilot trial of inosine to elevate urate levels in amyotrophic lateral sclerosis

Albert A. Taylor, S. Paganoni, M. Cudkowicz, 2018, Annals of clinical and translational neurology.

Improved stratification of ALS clinical trials using predicted survival

Albert A. Taylor, B. Ravina, J. Berry, 2018, Annals of clinical and translational neurology.

Design and analysis of a clinical trial using previous trials as historical control

Albert A. Taylor, D. Schoenfeld, D. Finkelstein, 2019, Clinical trials.

Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?

Albert A. Taylor, M. Cudkowicz, D. Ennist, 2015, Neurotherapeutics.

Modulation of Immune Responses by Surface Polysaccharides

D. Ennist, P. Baker, K. Elkins, 1988 .

Mechanisms of age related changes in cell mediated immunity

D. Ennist, K. H. Jones, 1985 .

Predicting disease progression in amyotrophic lateral sclerosis

Neta Zach, Albert A. Taylor, Mike Keymer, 2016, Annals of clinical and translational neurology.

Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemic

S. Paganoni, J. Glass, J. Berry, 2021, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Linked Tumor-Selective Virus Replication and Transgene Expression from E3-Containing Oncolytic Adenoviruses

J. Bristol, D. Ennist, S. Forry-Schaudies, 2005, Journal of Virology.

Improving clinical trial efficiency with machine learning models of disease progression

Albert A. Taylor, D. Ennist, M. Schactman, 2021 .

ALSUntangled #70: caffeine

Gary L. Pattee, M. Benatar, M. Bromberg, 2023, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Cloned trans-acting factors that bind to the regulatory elements of the major histocompatibility complex class I gene.

E. Appella, S. Hirschfeld, K. Ozato, 1990 .

ALSUntangled #71: Nuedexta.

M. Benatar, M. Bromberg, P. Barkhaus, 2023, Amyotrophic lateral sclerosis & frontotemporal degeneration.

The proper use of historical controls in ALS trials

D. Schoenfeld, D. Ennist, N. Zach, 2016 .

Functional analysis of the immunosenescence of the human B cell system: dissociation of normal activation and proliferation from impaired terminal differentiation into IgM immunoglobulin-secreting cells.

D. Ennist, R. Whisler, R. L. Pierre, 1986, Journal of immunology.